January 1, 1995Journal of Internal Medicine
The cost‐effectiveness of a cardiovascular multiple‐risk‐factor intervention programme in treated hypertensive men
Why the study?
Does a comprehensive multiple-risk factor modification programme improve cost-effectiveness (incremental cost per life-year gained) in treated hypertensive men with additional risk factors?
Population
508 treated hypertensive men, age 50-72 years, with at least one of the following: serum cholesterol ≥ 6.5…
Comparison
Comprehensive, multiple-risk factor modification… vs Conventional treatment.
Design
RCT, randomized, parallel-group, open
Follow-up
3 years
Authors
Discussion
Loading...
Member takes
Implication
Supports adoption of multiple-risk factor programs in high-risk hypertensive men; confirms cost-effectiveness using observed outcomes over modeled estimates.
Structured PICO
Does a comprehensive multiple-risk factor modification programme improve cost-effectiveness (incremental cost per life-year gained) in treated hypertensive men with additional risk factors?
P
Population
508 treated hypertensive men, age 50-72 (mean 66.4) years, with at least one of the following: serum cholesterol ≥ 6.5 mmol/L, smoking, or diabetes mellitus.
I
Intervention
Comprehensive, multiple-risk factor modification programme including individual advice, group meetings based on nutritional advice and behavioural treatment principles, and drug therapy if necessary to achieve treatment goals (serum total cholesterol < 6.0 mmol/L, no smoking, HbA1c < 6.0%, and diastolic blood pressure < 90 mmHg).
C
Comparator
Conventional treatment.
O
Outcome
Incremental cost per life-year gained of the intervention programme.
A comprehensive multiple-risk factor modification program is cost-effective in treated hypertensive men with additional cardiovascular risk factors.
Cite This Study
Johannesson et al. (1995) studied this question.